• xmlui.mirage2.page-structure.header.title
    • français
    • English
  • Help
  • Login
  • Language 
    • Français
    • English
View Item 
  •   BIRD Home
  • LEDa (UMR CNRS 8007, UMR IRD 260)
  • LEDa : Publications
  • View Item
  •   BIRD Home
  • LEDa (UMR CNRS 8007, UMR IRD 260)
  • LEDa : Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browse

BIRDResearch centres & CollectionsBy Issue DateAuthorsTitlesTypeThis CollectionBy Issue DateAuthorsTitlesType

My Account

LoginRegister

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors
Thumbnail

Potential Budgetary Impact of Large Scale Screening of Small Fiber Neuropathy in the Follow-Up of Patients with Type 2 Diabetes in France

Lévy, Pierre; Bordier, Lyse; Calvet, Jean-Henri; Le Hérissé, Gaëlle; Bauduceau, Bernard (2015), Potential Budgetary Impact of Large Scale Screening of Small Fiber Neuropathy in the Follow-Up of Patients with Type 2 Diabetes in France, Journal of Diabetes & Metabolism, 6, 10. 10.4172/2155-6156.1000618

View/Open
potential-budgetary-impact-of-large-scale-screening.pdf (502.5Kb)
Type
Article accepté pour publication ou publié
Date
2015
Journal name
Journal of Diabetes & Metabolism
Volume
6
Number
10
Publisher
OMICS International
Publication identifier
10.4172/2155-6156.1000618
Metadata
Show full item record
Author(s)
Lévy, Pierre
Laboratoire d'Economie de Dauphine [LEDa]
Bordier, Lyse
Hôpital d'Instruction des Armées Begin
Calvet, Jean-Henri

Le Hérissé, Gaëlle

Bauduceau, Bernard
Hôpital d'Instruction des Armées Begin
Abstract (EN)
Aims: The burden of diabetes-related complications is important and increasing in France. Early screening of microvascular complications could avoid the occurrence of more severe consequences. An economic model using a 5-year time horizon was developed to estimate the potential impact in France of large screening of diabetic autonomic neuropathy using Sudoscan, a quick, non-invasive and quantitative method developed for screening of small fiber neuropathy. Methods: A disease progression model was first developed to describe the long-term evolution of patients with type 2 diabetes regarding microvascular complications over successive time periods and patients were classified in 4 groups according to the severity. Complication-related costs were then calculated for a cohort of patients treated according to the current pattern of care and compared with the costs incurred by the same cohort assuming the introduction and widespread use of a large screening of small fiber neuropathy using the Sudoscan method. Comparison of treatment costs between the two situations was used to evaluate the potential budget impact of such a prevention policy in France. Results: According to this general screening of early complications more than 25,000 patients could avoid more severe complications. The gross benefit of such a new prevention strategy would be around € 280 million at 5th year. After 5 years of follow-up, the cumulated gross benefit would be € 837 million and in the worst case scenario (decrease of 20% for each uncertain parameter, namely the distribution of patients among severity groups, the death rates in each severity group, and the distribution of newly diagnosed patients in each severity group) gross benefit would remain at more than € 50 million for the first year and more than € 255 million at the 5th year (using 6% as global efficacy of screening method as basal value). Conclusion: Large screening of small fiber neuropathy could avoid more severe peripheral neuropathy and consequently decrease the burden related to such complications for a limited investment.
Subjects / Keywords
Microvascular complications; Diabetic autonomicneuropathy; Sudomotor function; Prevention program
JEL
I18 - Government Policy; Regulation; Public Health

Related items

Showing items related by title and author.

  • Thumbnail
    FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes 
    Pochopień, M. T.; Cherney, D. Z. I.; Folkerts, K.; Lévy, Pierre; Millier, Aurélie; Morris, S.; Roy-Chaudhury, P.; Sullivan, S. D.; Mernagh, P. (2021) Article accepté pour publication ou publié
  • Thumbnail
    Impact of methodological choices on a meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation 
    Briere, Jean-Baptiste; Wu, Olivia; Bowrin, Kevin; Millier, Aurélie; Toumi, Mondher; Taieb, Vanessa; Lévy, Pierre; Coleman, Craig I. (2019) Article accepté pour publication ou publié
  • Thumbnail
    Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study 
    De Caterina, Raffaele; Kelly, Peter; Monteiro, Pedro; Deharo, Jean Claude; de Asmundis, Carlo; López-de-Sá, Esteban; Weiss, Thomas W.; Waltenberger, Johannes; Steffel, Jan; de Groot, Joris R.; Lévy, Pierre; Bakhai, Ameet; Zierhut, Wolfgang; Laeis, Petra; Reimitz, Paul-Egbert; Kirchhof, Paulus (2019) Article accepté pour publication ou publié
  • Thumbnail
    Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective 
    Lévy, Pierre; Smadja, David M.; Dorey, Julie; Toumi, Mondher; Meinecke, Anna-Katharina; Bowrin, Kevin; Briere, Jean-Baptiste (2019) Article accepté pour publication ou publié
  • Thumbnail
    The Comparative Effects of Bariatric Surgery on Weight and Type 2 Diabetes 
    Lévy, Pierre; Fried, Martin; Santini, Ferruccio; Finer, Nick (2007) Article accepté pour publication ou publié
Dauphine PSL Bibliothèque logo
Place du Maréchal de Lattre de Tassigny 75775 Paris Cedex 16
Phone: 01 44 05 40 94
Contact
Dauphine PSL logoEQUIS logoCreative Commons logo